Clinical trial
Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)
NCT00116571 · QLT Inc., Industry · Terminated
Key facts
| NCT number | NCT00116571 |
|---|---|
| Title | Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) |
| Official title | A Phase II Randomized, Sham-Controlled, Double-Blind, Dose-Finding Study to Assess the Efficacy and Safety of Transurethral Photodynamic Therapy With Lemuteporfin in Subjects With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia |
| Lead sponsor | QLT Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia |
| Intervention type | Device, Drug |
| Interventions | Lemuteporfin for injection, Transurethral drug delivery system, Transurethral light delivery system |
| Enrollment | 180 |
| Start date | May 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Jun 30, 2005 |
| Last update posted | Oct 3, 2006 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: